Related references
Note: Only part of the references are listed.Impact of Pharmacological Treatments for Chronic Spontaneous Urticaria with an Inadequate Response to H1-Antihistamines on Health-Related Quality of Life: A Systematic Review and Network Meta-Analysis
Surapon Nochaiwong et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)
Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis
Viktor A. Zouboulis et al.
PHARMACEUTICS (2022)
Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials
Aditya K. Gupta et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Dapsone in Hidradenitis Suppurativa: A Systematic Review
Aswatha Rabindranathnambi et al.
DERMATOLOGY AND THERAPY (2022)
Treatment Outcomes of IL-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review
Nadia Kashetsky et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2022)
Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa
Shari Wright et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
A Comparison of International Management Guidelines for Hidradenitis Suppurativa
Aleksi J. Hendricks et al.
DERMATOLOGY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Evaluation of Pharmacologic Treatments for H1 Antihistamine-Refractory Chronic Spontaneous Urticaria A Systematic Review and Network Meta-analysis
Surapon Nochaiwong et al.
JAMA DERMATOLOGY (2021)
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial
Sophie Glatt et al.
JAMA DERMATOLOGY (2021)
New perspectives on the treatment of hidradenitis suppurativa
Victoria Amat-Samaranch et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2021)
CINeMA: An approach for assessing confidence in the results of a network meta-analysis
Adriani Nikolakopoulou et al.
PLOS MEDICINE (2020)
Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study
Oystein Grimstad et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
When to replicate systematic reviews of interventions: consensus checklist
Peter Tugwell et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
The Efficacy and Effectiveness of Non-ablative Light-Based Devices in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis
Abdulhadi Jfri et al.
FRONTIERS IN MEDICINE (2020)
Cost-savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real-world cohort
M. Argyropoulou et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part I: Diagnosis, evaluation, and the use of complementary and procedural management
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Increased Suicide Risk in Patients with Hidradenitis Suppurativa
Linnea Thorlacius et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Hidradenitis Suppurativa Advances in Diagnosis and Treatment
Ditte Marie Lindhardt Saunte et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
A pilot study of unemployment in patients with hidradenitis suppurativa in Denmark
P. Theut Riis et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B. Kimball et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa A Randomized Clinical Trial
Vassiliki Tzanetakou et al.
JAMA DERMATOLOGY (2016)
Recognizing and Managing Comorbidities and Complications in Hidradenitis Suppurativa
Alan Menter et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa
Raed Alhusayen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis
Ali Mehdizadeh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
Joanna IntHout et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis
Julia Shlyankevich et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
Milo A. Puhan et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers
Jeroen P. Jansen et al.
BMC MEDICINE (2013)
Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study
Florence Canoui-Poitrine et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Graphical Tools for Network Meta-Analysis in STATA
Anna Chaimani et al.
PLOS ONE (2013)
Pharmacologic Interventions for Hidradenitis Suppurativa What Does the Evidence Say?
Raed Alhusayen et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
J. P. T. Higgins et al.
RESEARCH SYNTHESIS METHODS (2012)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
How Big is a Big Odds Ratio? Interpreting the Magnitudes of Odds Ratios in Epidemiological Studies
Henian Chen et al.
COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION (2010)
Share Paper
